Injective: Rwa Perpetual Activity Intensifying
- Cumulative RWA perpetual volume on Injective totals ~$1.68 billion YTD.
- Equities account for $1.18 billion, FX for $187.2 million, commodities for $146.3 million, and Indexes for $162.3 million.
- Equities account for 70.4% of the total RWA volume traded on Injective YTD.
- Trading volume on stocks in the Magnificent 7 achieved a 41.6% market share as the most traded assets among Injectives' RWA offerings.
What Happened
Injective introduced a perpetual tied to Nvidia H100 GPU rental rates in August 2025. This is Injective’s first exotic perpetual implementation and opens the door for additional exotic financial primitives for hedging and speculation.
Building on the iAssets framework, Injective has introduced perpetual futures markets across a diverse range of real-world assets. Equities have become the largest segment, with markets for the “Magnificent 7” (Mag 7) technology stocks, including Nvidia, Tesla, Apple, Amazon, Microsoft, Meta, and Alphabet, alongside other listed companies such as Coinbase, MicroStrategy, and Robinhood. In addition to single-stock exposure, Injective also supports index perpetuals, including the TradFi Stocks Index (TRADFI), a basket of hundreds of large-cap U.S. equities; the TradFi Tech Stock Index (TTI), covering one hundred of the largest non-financial U.S. equities; and the Helix AI Index (AIX), which combines AI-focused tokens with AI-related equities. These equity markets are among the most actively traded on Injective and demonstrate how onchain infrastructure can replicate traditional stock exposure in a 24/7 environment.
In addition to equities, Injective lists commodity contracts for gold, silver, and crude oil, as well as foreign exchange pairs such as the euro and British Pound. These markets bring asset classes that typically depend on centralized venues into a decentralized setting, where pricing is sourced from oracles and all trades are executed through Injective’s onchain central limit order book. Experimental markets have also been introduced, most notably a perpetual contract linked to the rental rates of Nvidia’s H100 GPUs. While volumes in these contracts are currently limited, they illustrate Injective’s capacity to extend the iAssets framework into novel and unconventional markets.
Injective’s RWA perpetuals have scaled rapidly in 2025, with cumulative trading volume reaching $1.68 billion as of Aug. 20, 2025. Daily activity has accelerated since March following the launch of equity perps, pushing Injective’s RWA markets to an annualized trading volume of approximately $2.51 billion. The combination of a steady upward trajectory in cumulative volume and increasingly frequent high-volume days underscores both rising adoption and improving liquidity conditions.
Market Context
Cumulative RWA perpetual volume on Injective totals ~$1.68 billion YTD. Equities account for $1.18 billion, FX for $187.2 million, commodities for $146.3 million, and Indexes for $162.3 million.
Equities account for 70.4% of the total RWA volume traded on Injective YTD. Trading volume on stocks in the Magnificent 7 achieved a 41.6% market share as the most traded assets among Injectives' RWA offerings.
Injective is a Layer-1 (L1) blockchain purpose-built for financial primitives. Founded in 2018 and incubated by Binance Labs, Injective leverages the Cosmos SDK to provide a high-performance execution layer tailored for derivatives, trading, and real-world asset markets. Injective integrates a native exchange module with an onchain central limit order book (CLOB), oracle connectivity, and shared liquidity, enabling financial instruments to be created and traded directly onchain. This design distinguishes Injective from CDP-based synthetic protocols by avoiding pre-funded collateral pools and instead relying on market makers to provide depth and dynamically allocate capital.
Injective delivers real-world exposure onchain through its iAssets framework, which enables programmable instruments that track the value of traditional assets. Using oracle-based pricing and Injective’s onchain order book, iAssets allow the creation of perpetual futures across equities, commodities, foreign exchange, and even more experimental markets such as Nvidia H100 GPU rental rates. This framework gives traders 24/7 access to markets that traditionally depend on centralized venues, supported by institutional market makers that help ensure liquidity.
To support its long-term vision, Injective has attracted substantial venture funding, raising over $59.9 million across multiple funding rounds, including a $10.0 million strategic funding round in April 2021 backed by Mark Cuban, Pantera Capital, CMS Holdings, BlockTower, and Hashed Ventures and a $40.0 million private token sale in August 2022, led by Jump Crypto and Brevan Howard.
Injective’s Role in Onchain Markets
Injective is a general-purpose infrastructure layer for onchain finance, offering a range of decentralized trading and financial products, including real-world assets (RWAs). The protocol’s exchange module supports spot and perpetual markets, derivatives, and structured products that trade on an onchain central limit order book (CLOB). Injective integrates oracles for accurate price discovery, enables cross-chain asset transfers through IBC and bridges like Wormhole and Peggy, and relies on a decentralized set of professional liquidity providers to provide depth to the order book. These features have allowed Injective to cultivate an ecosystem that spans decentralized exchanges, derivatives protocols, RWAs, and more. Within this broader design, RWA perpetuals represent one of Injective’s most recent additions, extending Injective’s model to equities, commodities, forex, and more exotic assets such as Nvidia H100 GPU rental rates.
At the core of Injective’s RWA markets is the iAssets framework, a system for creating programmable instruments that track the value of offchain assets. Each iAsset is priced through oracle feeds and instantiated as a tradable market on Injective’s exchange module. Unlike earlier synthetic asset models that rely on overcollateralized debt positions, iAssets do not require users to pre-fund issuance with excess collateral. Instead, liquidity is provided by professional market makers who supply depth and dynamically allocate capital, while traders interact directly through the onchain CLOB.
The framework improves capital efficiency by separating collateral requirements for trading from the mechanics of asset creation. iAssets can be used across the Injective ecosystem in the same way as native crypto assets: they can serve as collateral for leveraged positions, be integrated into structured products for automated hedging, or composed into secondary markets and algorithmic strategies. By combining oracle-based pricing, exchange-native settlement, and flexible integration points, iAssets provides the technical foundation for Injective’s expansion into real-world assets.
All iAssets on Injective share a consistent risk and collateral framework. Oracle feeds deliver reference prices, perpetual markets are instantiated on the exchange module, and professional market makers provide liquidity while adjusting positions in response to demand. Users post margin to take positions, but the system does not rely on over-collateralized debt positions to issue the assets themselves. This model improves capital efficiency compared with CDP-based synthetics. Leverage parameters are defined for each market and enforced within the derivatives engine, allowing risk management to remain programmatic while ensuring continuous market access.
RWA Volume on Injective
While absolute figures remain small compared to traditional brokerages, Injective’s growth demonstrates that fully onchain infrastructure can sustain multi-billion-dollar volumes in real-world asset markets. The ability to offer equities, commodities, foreign exchange, and experimental contracts within the same framework has positioned Injective as one of the most diversified and liquid venues for onchain RWAs.
Market Share by Asset Category
Equities have driven the majority of Injective’s RWA perpetual activity in 2025, accounting for over 70.4% of total trading volume. Growth accelerated sharply in July, particularly among the Magnificent 7 stocks, which quickly became the most active contracts on the platform. Other categories, such as forex, commodities, and indices, have also gained traction.
Why It Matters
Key Insights
Through Injective’s iAsset, traders can access up to 25x leverage on stocks, 50x leverage on commodities, and 100x leverage on forex pairs. iAssets can also be traded 24/7, support advanced order types, and be integrated into automated strategies.
Details
Primer
Website / X (Twitter) / Discord
iAssets
Injective’s RWA Perpetuals Offering